Key Points
- Astera Labs General Counsel Philip Mazzara sold 10,000 shares on March 2 at an average price of $117.47 for roughly $1.1747M, trimming his stake by 7.24% to 128,084 shares (≈$15.05M); the transaction was disclosed in an SEC filing.
- Mazzara also sold 4,849 shares on February 17 at an average of $123.80 (≈$600.3K), signaling multiple recent insider sales.
- Astera Labs beat quarterly estimates with $0.58 EPS vs. $0.51 expected and revenue of $270.58M (up 91.8% YoY); the company has a market cap of about $19.37B and a consensus analyst rating of "Moderate Buy" with a $195.89 price target.
Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $117.47, for a total transaction of $1,174,700.00. Following the completion of the sale, the general counsel directly owned 128,084 shares of the company's stock, valued at approximately $15,046,027.48. This trade represents a 7.24% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Philip Mazzara also recently made the following trade(s):
- On Tuesday, February 17th, Philip Mazzara sold 4,849 shares of Astera Labs stock. The shares were sold at an average price of $123.80, for a total value of $600,306.20.
Astera Labs Price Performance
Shares of Astera Labs stock opened at $113.77 on Thursday. The business has a 50-day simple moving average of $154.84 and a 200 day simple moving average of $170.88. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The firm has a market capitalization of $19.37 billion, a price-to-earnings ratio of 93.25, a PEG ratio of 2.16 and a beta of 1.74.
Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The firm had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. During the same quarter in the previous year, the company posted $0.37 earnings per share. The company's quarterly revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.
Analyst Upgrades and Downgrades
Several equities analysts recently weighed in on ALAB shares. JPMorgan Chase & Co. raised their price target on shares of Astera Labs from $180.00 to $215.00 and gave the company an "overweight" rating in a research report on Wednesday, November 5th. Barclays set a $165.00 price target on Astera Labs in a research report on Thursday, January 15th. Northland Securities increased their target price on shares of Astera Labs from $175.00 to $195.00 and gave the company an "outperform" rating in a report on Tuesday, December 9th. Stifel Nicolaus upped their price objective on shares of Astera Labs from $185.00 to $200.00 and gave the stock a "buy" rating in a research report on Wednesday, November 5th. Finally, BNP Paribas Exane began coverage on shares of Astera Labs in a research report on Thursday, November 20th. They set an "outperform" rating on the stock. Fifteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $195.89.
Read Our Latest Stock Analysis on ALAB
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in ALAB. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of Astera Labs by 94.6% during the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 109,576 shares of the company's stock worth $9,908,000 after acquiring an additional 53,276 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in Astera Labs by 34.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 522,093 shares of the company's stock worth $47,208,000 after purchasing an additional 133,961 shares during the period. Geneva Partners LLC purchased a new position in Astera Labs during the 3rd quarter valued at about $1,876,000. Corient Private Wealth LLC purchased a new stake in shares of Astera Labs in the second quarter worth about $543,000. Finally, Paragon Advisors LLC purchased a new position in Astera Labs during the third quarter valued at approximately $1,829,000. Institutional investors own 60.47% of the company's stock.
About Astera Labs
(
Get Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
